Skip to content

Effect of Care Management on Diabetes Outcomes

Effect of Care Management on Diabetes Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00569556
Enrollment
550
Registered
2007-12-07
Start date
2006-09-30
Completion date
2009-05-31
Last updated
2009-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes Mellitus, Chronic Care Model, Case Management

Brief summary

The purpose of the study is to determine if a nurse managed, protocol driven, disease management process for diabetes results in improved attainment of therapeutic goals for diabetes compared to usual care. It is hypothesized that implementation of the disease management process will improve the percentage of diabetic individuals attaining all three therapeutic targets (HgbA1C\<8.0%, LDL\<100mg/dl, and BP\<130/80mmHG) by 10% compared to usual care.

Interventions

OTHERCase Management

Phone contact by specially trained nurse case managers; lifestyle recommendations and medication changes as needed

Sponsors

Minneapolis Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled at Minneapolis VAMC * Type 1 or 2 diabetes * Blood pressure at screening visit \> 140mmHg systolic or \> 90mmHg diastolic OR HgbA1C at screening visit \> 9.0% OR LDL at screening visit \> 100mg/dL

Exclusion criteria

* Primary care provider unwilling to have participant included in study * Life expectancy \< 1 year * Unable to give consent * Severe mental health condition * pregnant or planning on becoming pregnant

Design outcomes

Primary

MeasureTime frame
Combined outcome of BP<130/80 mmHG, HgbA1C<8%, and LDL<100mg/dl at 1 year; the primary analysis will compare the intervention to usual care with respect to the percentage of diabetic individuals achieving all three therapeutic goalsone year

Secondary

MeasureTime frame
Safety of the intervention (occurence of adverse events over the course of the trial)one year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026